Fremont, CA – December 14, 2006

Velos, Inc., the recognized leader and trusted resource for clinical trial information systems, announced today its continued leadership in cancer research. With a proven track record in all parts of the healthcare research enterprise, Velos also aligns its products and services by disease area with particular strength in cancer research.

One hundred Cancer Centers conduct approximately 80% of extramural clinical research funded by the National Cancer Institute (NCI). Velos customers receive more than 35 percent of such NCI funding – a market share that leads all competitors by a wide margin. More than 25 departments and specializations associated with cancer use Velos eResearch today (listed below).

While noteworthy in itself, the significant market penetration is also relevant as the next wave of benefits start to accrue to Velos customers. Velos is helping the research community extend “Electronic Data Capture,” where research systems generally provided by industry sponsors are used to capture research data, to “Direct Data Capture,” where systems actually used at the site can generate high quality research data. Velos is solving in clinical research what the telecommunications industry calls the “last mile problem.” With the Velos approach, networked investigators can conduct FDA-quality research with systems they use on a day-to-day basis and sponsors are no longer once-removed from the research system used at the investigator sites. Industry sponsors and investigators alike expect this direct approach to be faster, more reliable, and less expensive. Research sites equipped with Velos increase or reinforce their value position in the clinical research supply chain.

About Velos
Velos is the trusted clinical trial management resource for investigators, sponsors and academic leaders throughout the U.S. Velos eResearch is deployed for clinical research in all parts of the healthcare enterprise and supports a broad diversity of clinical departments and functional needs. The system fundamentally improves the way data is collected, organized and shared. A pure Internet technology platform, Velos eResearch harnesses advanced powers of the Internet to enable research sites, sponsors, and patients to collaborate in a secure, integrated system platform. System users are freed of redundant data entry and related time delays associated with most clinical research today. With emphasis on workflow, Velos integrates the clinical, administrative and financial information needs of research management. Founded in 1996, Velos is privately held with headquarters in Fremont, California. For more information, visit http://www.velos.com/

Departmental and specialty areas associated with cancer using Velos eResearch include:

This press release may contain forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those set forth in the forward-looking statements.